Acadia Pharmaceuticals | ACAD - Acreedores Comerciales

Precio De Mercado
20.73
Cambio Diario
0.01 0.05%
Mensual
-16.17%
Anual
23.47%
Q1 Expectativa
19.99




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cara Therapeutics USD 2.42M 2.42M 2025-06
Corcept Therapeutics USD 40.44M 6M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Incyte USD 1.63B 1.46B 2025-12
J&J USD 11.99B 2.37B 2025-12
Moderna USD 317M 50M 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pfizer USD 5.02B 142M 2025-09
Prothena USD 5.88M 4.63M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12